The translocation t (9;22), also known as Philadelphia (Ph)-chromosome, was identified as the hallmark of CML (3), and the subsequent identified BCR-ABL1 fusion gene is the central player in the pathogenesis of CML. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.